012348AC2

• Net income attributable to the Company was $17.4 million, or diluted EPS of $0.61, up from $9.2 million and $0.31 in the prior year.
• Adjusted EBITDA was $57.8 million, up 11.5% from $51.9 million in Q2 2025; Adjusted EPS was $0.82, up from $0.57.
• Engineered Composites net revenue increased 14.2% (currency-adjusted), while Machine Clothing net revenue decreased 2.4% (currency-adjusted).
• For Q3 2026, the company guides consolidated net revenue of $320-$330 million and Adjusted EPS of $0.60-$0.70.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• The appointment of KPMG LLP as independent auditor was ratified with 25,067,522 votes for, 1,187,962 against, and 251 abstentions.
• The non-binding advisory vote on executive compensation was approved with 24,867,270 votes for, 324,433 against, and 183,108 abstentions.
• Broker non-votes totaled 880,924 for each director election and for the executive compensation vote.
• The report was filed on May 19, 2026, under Item 5.07 to disclose the results of these shareholder votes.

5.07 Submission of Matters to a Vote of Security Holders

• Q1 2026 net revenue was $311.3 million, compared to $288.8 million in Q1 2025.
• Adjusted EBITDA was $48.2 million (15.5% margin) and Adjusted EPS was $0.60, compared to $55.7 million (19.3% margin) and $0.73 in Q1 2025.
• The company issued Q2 2026 guidance: consolidated revenue between $335 million and $345 million, and Adjusted EPS between $0.70 and $0.80.
• Machine Clothing revenue declined 8.5% on a constant currency basis, while Engineered Composites revenue increased 24.7% on the same basis.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Q4 2025 net revenue was $321.2 million, compared to $286.9 million in Q4 2024.
• Adjusted EBITDA was $57.3 million in Q4 2025, up from $50.0 million in Q4 2024; Adjusted EPS was $0.65, up from $0.58.
• The company repurchased 360,267 shares for $16.8 million, paid $7.9 million in dividends, and invested $22.7 million in capital in Q4 2025.
• For Q1 2026, the company guides consolidated revenue between $275 million and $285 million and Adjusted EPS between $0.50 and $0.60.

2.02 Results of Operations and Financial Condition · 9.01 Financial Statements and Exhibits

• Albany International is exploring strategic alternatives for its structures assembly business, including a potential sale of all or part of the Amelia Earhart Drive (AED) Facility in Salt Lake City.
• Interest so far has come from more than ten private equity investors, not strategic investors.
• The company is in ongoing discussions with a customer about potential contract modifications to offset cost increases.
• If a divestiture is completed, the company expects the Adjusted EBITDA margin for the Albany Engineered Composites segment to be in the mid to high teens.

7.01 Regulation FD Disclosure

• The loss includes a $147.3 million pre-tax loss reserve and program adjustments on the CH-53K program, which also reduced revenue by $46.0 million in the quarter.
• The company initiated a strategic review of its structures assembly business and its Salt Lake City production site, including a potential sale, and reached a definitive agreement to conclude the Gulfstream contract by year-end.
• Adjusted net income was $20.6 million ($0.71 per diluted share) in Q3 2025, compared to $35.2 million ($1.12 per share) in Q3 2024, excluding CH-53K impacts.
• The company repurchased $50.5 million of common stock, paid $8.0 million in dividends, and withdrew its full-year guidance due to the strategic review.

9.01 Financial Statements and Exhibits

• The company expects to recognize an approximately $147 million loss reserve adjustment in the third quarter of 2025, primarily due to higher labor content and material inputs from inflation on the CH-53K contract.
• The CH-53K program is the only structure assembly program in the AEC segment and is operated by Albany Aerostructures Composites, LLC, a wholly-owned subsidiary.
• The entire Salt Lake City site generated approximately $130 million of revenue, after EAC charges, for the trailing twelve months ended September 30, 2025.
• Third-quarter 2025 results will be released on November 5, 2025, with a conference call and webcast on November 6, 2025.

2.02 Results of Operations and Financial Condition · 7.01 Regulation FD Disclosure · 9.01 Financial Statements and Exhibits

• Station succeeds Jairaj (JC) Chetnani, who had served as interim CFO since May 23, 2025.
• Station previously served as Senior Vice President of Primary Care Sales at McKesson Medical-Surgical since April 2024.
• His initial base salary is $600,000 per year, with eligibility for short-term and long-term incentive awards.
• He will receive a sign-on RSU award valued at $2.0 million and a severance agreement providing two times base salary.

5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements · 9.01 Financial Statements and Exhibits